April 14, 2010 - When college football’s elite enter Radio City Music Hall April 22 for the 2010 National Football League (NFL) draft, it will be after much public analysis of their stats and accomplishments. Also important to a player’s prospect of being drafted is the outcome of diagnostic tests including X-rays, magnetic resonance imaging (MRI) and cardiac evaluations.

April 13, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a combined electrocardiogram (ECG) Holter and ambulatory blood pressure monitoring recorder and software analysis system.

April 13, 2010 – A catheter designed to deliver embolic materials and radiopaque media to selected sites in visceral vascular territories recently gained FDA clearance. The Gandras Visci-G is a 5 French, 75 cm catheter with a primary curve and a flexible 1 cm tip, making it useful for precise and stable placement in renal, mesenteric or abdominal catheterization procedures.

April 13, 2010 – More than 300 patients in Europe have been enrolled in a real-world study to assess the effectiveness of a coronary bifurcation stent. Enrollment was completed last week in E-Tryton 150 and E-Tryton Benelux, two European registry studies evaluating the Tryton Side Branch Stent System for the treatment of atherosclerotic lesions in the side branch at the site of a bifurcation.


April 13, 2010 – Obstructive sleep apnea is associated with an increased risk of stroke in middle-aged and older adults, especially men, according to new results from a landmark study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Overall, sleep apnea more than doubles the risk of stroke in men.

April 9, 2010 – The first patients have been enrolled in the INNOVATION trial, which will assess the safety of a new stent graft system to treat abdominal aortic aneurisms (AAA).

April 9, 2010 – A survey of physicians by Majestic Research found that Boston Scientific’s March 15 decision to withdraw from the implantable cardioverter defibrillator (ICD) market will have a meaningful, long-term impact on the implantable electrophysiology device market.

April 9, 2010 – A preclinical study shows the action of a toll-like receptor (TLR) antagonist helps reduce atherosclerosis in mice.

April 7, 2010 – A medical manufacturer pleaded guilty Monday to criminal violations for improper reporting of short-circuit failures of three models of its implantable cardioverter defibrillators (ICDs), the Justice Department announced. The company also agreed to pay more than $296 million in damages.

April 7, 2010 – The U.S. Food and Drug Administration (FDA) recently sent a warning letter to Edwards Lifesciences Corp. for late reporting of adverse events with its medical devices.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now